Flavia Melo Cunha DE Pinho Pessoa
Overview
Explore the profile of Flavia Melo Cunha DE Pinho Pessoa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
27
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
DE Oliveira Sales L, DA Silva J, DE Pinho Pessoa F, Dias Nogueira B, DE Oliveira L, Khayat A, et al.
In Vivo
. 2024 Oct;
38(6):2853-2863.
PMID: 39477442
Background/aim: SARS-CoV-2 infection presents different severity levels that suggest the influence of genetic factors on the clinical outcome of the disease. In cases of severe COVID-19, the presence of elevated...
2.
DE Morais G, Machado C, Dias Nogueira B, DE Pinho Pessoa F, DE Sousa Oliveira D, Ribeiro R, et al.
Cancer Diagn Progn
. 2024 Sep;
4(5):592-598.
PMID: 39238631
Background/aim: Although the reciprocal translocation t(9;22)(q34;q11) is a hallmark of chronic myeloid leukemia (CML), it is also present in acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). Depending on...
3.
DE Pinho Pessoa F, Dias Nogueira B, Machado C, Barreto I, DA Costa Machado A, Gadelha R, et al.
In Vivo
. 2024 Jun;
38(4):2016-2023.
PMID: 38936913
Background/aim: Acute myeloid leukemia (AML) is a myeloproliferative neoplasm marked by abnormal clonal expansion of hematopoietic progenitor cells, displaying karyotypic aberrations and genetic mutations as prognostic indicators. The World Health...
4.
DE Pinho Pessoa F, DE Sousa Oliveira D, Dias Nogueira B, DE Albuquerque K, Silva F, Gurgel L, et al.
Anticancer Res
. 2024 May;
44(6):2747-2753.
PMID: 38821591
Background/aim: The relevance of cytogenetic markers as prognostic risk factors has been demonstrated in a vast number of studies, with many prognostication tools utilizing these factors to determine treatment approaches....
5.
DE Pinho Pessoa F, Viana V, de Oliveira M, Dias Nogueira B, Ribeiro R, DE Sousa Oliveira D, et al.
Genes (Basel)
. 2024 Feb;
15(2).
PMID: 38397141
Reference genes are used as internal reaction controls for gene expression analysis, and for this reason, they are considered reliable and must meet several important criteria. In view of the...
6.
DA Costa Machado A, Machado C, DE Pinho Pessoa F, Barreto I, Gadelha R, DE Sousa Oliveira D, et al.
Cancer Diagn Progn
. 2024 Jan;
4(1):9-24.
PMID: 38173664
Leukemias are hematological neoplasms characterized by dysregulations in several cellular signaling pathways, prominently including the PI3K/AKT/mTOR pathway. Since this pathway is associated with several important cellular mechanisms, such as proliferation,...
7.
Machado C, da Silva E, Ferreira W, DE Pinho Pessoa F, de Quadros A, Fantacini D, et al.
Cancers (Basel)
. 2023 Dec;
15(23).
PMID: 38067214
Detection of t(9;22), and consequent fusion, is still a marker of worse prognosis for acute lymphoblastic leukemia (ALL), with resistance to tyrosine-kinase inhibitor therapy being a major obstacle in the...
8.
DE Pinho Pessoa F, Machado C, Barreto I, Sampaio G, DE Sousa Oliveira D, Ribeiro R, et al.
Biomedicines
. 2023 May;
11(4).
PMID: 37189716
Acute myeloid leukemia (AML) is a hematologic malignancy that occurs due to alterations such as genetic mutations, chromosomal translocations, or changes in molecular levels. These alterations can accumulate in stem...
9.
Gadelha R, Machado C, DE Pinho Pessoa F, da Costa Pantoja L, Barreto I, Ribeiro R, et al.
Curr Issues Mol Biol
. 2022 Nov;
44(11):5498-5515.
PMID: 36354684
The WD repeat containing antisense to TP53 () gene codifies an antisense transcript for tumor protein p53 (), stabilization (WRAP53α), and a functional protein (WRAP53β, WDR79, or TCAB1). The WRAP53β...
10.
Barreto I, Machado C, Almeida D, DE Pinho Pessoa F, Gadelha R, da Costa Pantoja L, et al.
Pharmaceutics
. 2022 Sep;
14(9).
PMID: 36145532
Multiple myeloma (MM) is a blood cell neoplasm characterized by excessive production of malignant monoclonal plasma cells (activated B lymphocytes) by the bone marrow, which end up synthesizing antibodies or...